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Abstract
Background: Overdose is the most common cause of fatalities among opioid users. Naloxone is a life-saving
medication for reversing opioid overdose. In Ireland, it is currently available to ambulance and emergency care
services, but General Practitioners (GP) are in regular contact with opioid users and their families. This positions
them to provide naloxone themselves or to instruct patients how to use it. The new Clinical Practice Guidelines of
the Pre-hospital Emergency Care Council of Ireland allows trained bystanders to administer intranasal naloxone.
We describe the development and process evaluation of an educational intervention, designed to help GP trainees
identify and manage opioid overdose with intranasal naloxone.
Methods: Participants (N = 23) from one postgraduate training scheme in Ireland participated in a one-hour
training session. The repeated-measures design, using the validated Opioid Overdose Knowledge (OOKS) and
Attitudes (OOAS) Scales, examined changes immediately after training. Acceptability and satisfaction with training
were measured with a self-administered questionnaire.
Results: Knowledge of the risks of overdose and appropriate actions to be taken increased significantly post-training
[OOKS mean difference, 3.52 (standard deviation 4.45); P < 0.001]; attitudes improved too [OOAS mean difference,
11.13 (SD 6.38); P < 0.001]. The most and least useful delivery methods were simulation and video, respectively.
Conclusion: Appropriate training is a key requirement for the distribution of naloxone through general practice. In
future studies, the knowledge from this pilot will be used to inform a train-the-trainer model, whereby healthcare
professionals and other front-line service providers will be trained to instruct opioid users and their families in overdose
prevention and naloxone use.
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Background
Overdose is the most common cause of death among
people with opioid disorders and its prevention and
management are thus priorities for healthcare agencies
[1]. Europe has on average 17 drug-related deaths per
million people (15–64 years) per year, varying from
country to country [2]. With 70 drug-related deaths per
million, Ireland has the third highest rate in Europe [2, 3].
Ambulance services in Dublin attend to an opioid over-
dose every day [4]. The use of the opioid antagonist nalox-
one is well recognised as an effective treatment for opioid
overdose, and constitutes standard medical treatment in
such situations. However, to prevent death, naloxone must
be given very soon after the opioid has caused respiratory
depression or arrest [5]. To date, naloxone has generally
been used in injectable form, delivered via intramuscular,
intravenous or intraosseous routes. A number of interven-
tions to introduce naloxone to families, friends and drug
workers have been established in countries other than
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Ireland and report positive effects [1, 6, 7], such as reduced
death rates, less risk of needle stick injury or increased opi-
oid overdose-related knowledge and competence. Ireland
currently has no layperson distribution of naloxone; how-
ever, the government recently announced a lay demonstra-
tion project [8] which commenced in May 2015. Under
this project, a total of 600 people with opioid use disorders
will receive a multi-dose naloxone injector, a product with
up to five injectable doses, to take home. Given the preva-
lence of blood-borne infections among the target group,
the recent upsurge in HIV infections and many years of
strenuous efforts to minimise injecting risks, the pitfalls of
distributing a multi-dose injector have to be assessed. The
feasibility of expanding the distribution of less risky intra-
nasal naloxone via other channels such as primary care
has yet to be determined [9, 10].
Bystanders, specifically frontline service providers,
peers or family members of opioid users, are best posi-
tioned to intervene immediately when symptoms of
overdose first appear [11]. General Practitioners (GP) in
Ireland are also in regular contact with opioid users and
their families, either via methadone maintenance treat-
ment or other medical services in general practice. This
access should allow GPs to provide naloxone themselves,
or to instruct patients or family members on how to use
it. However, no structured provision of naloxone exists
in Irish general practice, and previous research else-
where has shown that GPs lack skills and knowledge
regarding naloxone administration and require more
training [12]. Our preliminary work suggested that this
training should include elements of the ‘Clinical Practice
Guidelines (CPG) approved by the Pre-Hospital Emergency
Care Council of Ireland in October 2013 (Emergency First
Response)’, specifically initiating contact with emergency
services, cardio-pulmonary resuscitation (CPR), and the
administration of intranasal naloxone (INN) [13, 14]. How-
ever, the feasibility and acceptability of such training for
GPs has not been previously reported. Therefore, the
current study aimed to:
– Develop an educational intervention that enables
doctors in specialist training for general practice to
support bystander response to overdose (i.e., initiating
contact with emergency services, CPR, etc.), and the
administration of intranasal naloxone (INN).
– Determine the potential feasibility, acceptability and
usefulness of this training to junGP trainees.
– Describe the process of development and evaluation.
Methods
Design, sample and intervention
Ireland’s population of 4.6 m is served by approximately
2,600 GPs; around 160 doctors enter one of 14
specialist-training programmes in GP each year. Each
programme is accredited nationally and follows a
standard four-year programme, the final two years of
which are spent in supervised training practices. 23
GP trainees from the Dublin Mid Leinster Specialist
Training Programme in general practice, affiliated with
University College Dublin, were invited to participate in a
one-hour training session. All accepted and took part in
the study voluntarily. At the time, they were based in
designated training general practices under the supervi-
sion of an accredited GP trainer.
Most practices were in Dublin (43 %), with 1000 or
more patients on their General Medical Services list – this
is a government subsidised health plan providing free
point of care primary care and medicines for those on low
incomes. Only six practices (26 %) prescribed methadone.
Most practices had one to three full-time GPs
(16, 70 %) and one to four part-time GPs (15, 83 %). More
than half of the practices had a practice nurse. Most
trainees (91 %) ranged from 25–34 years old, and most
were female (78 %). Eight (35 %) were trained methadone
prescribers and 11 (48 %) had witnessed an opioid
overdose (Table 1).
Ethical considerations/adherence to the International
guidelines
The Irish College of General Practitioners Research Ethics
Committee approved this study on August 27th, 2014. The
research on human participants carried out in this study is
in compliance with the Helsinki Declaration (http://
www.wma.net/en/30publications/10policies/b3/index.html).
This study adheres to the RATS guidelines on qualitative
research (http://www.biomedcentral.com/ifora/rats). We
informed the trainees about the study and gained their
consent one week before the educational session. Our
convenience sample is likely to be unrepresentative of the
national profile of doctors in specialist training for GP.
Development of the educational session
The educational session was developed as part of an
evolving system of lay delivered INN. The key compo-
nents of the system include:
1. A one-year prospective audit of the characteristics of
opioid overdoses reported to ambulance services in
Dublin [4, 15].
2. The development and implementation of CPG-led
administration of naloxone [16].
3. The exploration of mechanisms for roll-out of
naloxone by registered Medical Practitioners, since it
remains a prescription-only drug in Ireland.
As a first step, a national Naloxone Advisory Group
was established. A literature review on care options then
determined the intervention of choice, i.e. the intranasal
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formulation. While it appears to address safety, efficacy
and utility criteria, INN has not yet been approved by
the Irish Department of Health for general use; intra-
muscular naloxone is currently available for prescription
by doctors. However, an INN formulation is likely to
become available in coming months, and INN-oriented
training was identified as a long-term goal of the initiative.
Our subsequent steps followed the Medical Research
Council’s (MRC) framework, which advocates core phases
in the development of health services interventions: pre-
clinical, theoretical, modelling, exploratory trial, definitive
trial and long-term implementation [17]. While the term
preclinical usually refers to testing of interventions or
medications in non-humans, the MRC framework defines
its goal as: “Identifying the existing evidence and any
theoretical basis for the intervention in order to describe
the components of the intervention” (www.mrc.ac.uk/
complex_packages.html).
In the preclinical stage of the intervention develop-
ment, we identified a need and targets for naloxone
distribution by geo-locating urban overdose hotspots in
Dublin city – areas with high rates of overdoses [4].
They helped us to concentrate our efforts on general
Table 1 Sample characteristics
Number Percent
Profiles of training practices
County of practice
Dublin 10 43 %
Wicklow 8 35 %
Other 3 12 %
Missing data 2 10 %
GMS list size
<500 1 4 %
500–1000 4 17 %
1000–1500 7 30 %
1500–2000 2 9 %
>2000 8 35 %
Missing data 1 5 %
Practice setting
Urban 9 39 %
Rural 5 22 %
Mixed 8 35 %
Missing data 1 5 %
Mean number of GPs (excluding GP registrars)
Full time 2.6 (SD 2.0)
Part time 1.6 (SD 1.2)
Practice nurse 12 52 %
Active member of a Primary Care Team 11 48 %
Ever attended a primary care team meeting 6 26 %
Methadone prescribing 6 26 %
Level of methadone prescribing
Level 1 4 17 %
Level 2 2 9 %
N of patients receiving methadone in the practice
0–5 1 4 %
5–10 1 4 %
10–15 2 9 %
15–20 1 4 %
Years prescribing methadone
3 years 1 4 %
15+ years 2 8 %
Trainee profile
Age
25–34 years 21 91 %
35+ years 2 9 %
Year of Graduation
2008 5 22 %
2009 5 22 %
2010 4 17 %
Table 1 Sample characteristics (Continued)
2011 5 22 %
Other 3 12 %
Training in addiction
0 h 1 4 %
<4 h 3 13 %
4–10 h 7 30 %
11–40 h 2 9 %
>40 h 1 4 %
Trained in methadone prescribing
Level 1 8 35 %
None/Planned during training 15 65 %
(i) Ever witnessed an opioid overdose:
Hospital 9 39 %
Community 2 9 %
(ii) Total No of Witnessed Hospital overdoses 39a+
(iii) Total No of Witnessed Community overdoses 2
(iv) Ever administered Naloxone outside of
Emergency Department
5 22 %
Knowledge on Drugs in Ireland – Multiple-choice
questions
No of trainees who know how many people die
due to overdose every year in Ireland
10b 43 %
No of trainees who know how many people
are currently in methadone treatment in Ireland
8c 35 %
aOne trainee witnessed more than 10 hospital overdoses
bMultiple-choice question options: (i) < 100___(ii)200-300___(iii) > 300___
cMultiple-choice question options: (i) < 3000___(ii)3000-6000___ (iii) > 6000___
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and addiction care services in inner city Dublin. Our
participants were on training placements in practices
neighboring the inner city hotspots. The subsequent
modelling phase formulated clinical practice guidelines
(CPG). The Pre-hospital Emergency Care Council (PHECC,
the Statutory Regulator for Pre-Hospital Emergency Care
in Ireland) approved these guidelines in October 2013. The
UCD Centre for Emergency Medical Science concurrently
collaborated with PHECC and the Naloxone Advisory
Group to develop and pilot an educational session led by
the guidelines. The guidelines allow for the training of lay
people and health professionals in overdose prevention and
naloxone use, subject to previous CPR training.
The PHECC Clinical Practice Guidelines recommend
that naloxone training be provided as part of an overall
emergency care package that includes Basic Life Support
(BLS) skills training. There are two BLS levels prescribed
by PHECC:
– Cardiac First Response - Community (CFR).
– Cardiac First Response - Advanced (CFR-A).
All trainees were required to achieve the CFR stand-
ard as a prerequisite of the session - this was already
held by all participants. After the completion of this
pilot study, the session will be evaluated by a group of
community health professionals. Data from this feasi-
bility evaluation will inform the design of the final stage
of developing a national implementation for INN
distribution.
Content and delivery of the educational session
We based the intervention on our previous work, on
pre-implementation assessments from Scotland and on
training of family members to manage opioid overdose
and administer naloxone in England [6]. More specific-
ally, factors enabling naloxone distribution and use were
incorporated into the educational session: evidence of
effectiveness, appropriate training, and the development
of a policy regulation – the CPG – that would allow in-
tranasal administration [12, 18]. The intervention was
facilitated by:
– a small group session.
– a practical exercise.
– a video clip using content from: a) the family work
described in the above English study, b) the
introduction of take-home IN naloxone within the
National Health Service (NHS) Highland area [18].
– anonymous evaluation/feedback.
The video clip ensured the fidelity and consistency of
the information distribution. This is an evidence-based
methodology in emergency care training, and is used by
emergency services globally [19]. Multi-media theory
was reinforced at each stage with practical application
and exercises. The video was three minutes in duration
and its headings included:
– Recognition of overdose.
– Assembly of the drug administration system.
– INN administration.
The educational session was delivered by two facilitators
in a group setting, and lasted approximately 45 min. It
was held in the UCD Medical School. A manual for the
trainers was developed before the delivery of the session
in collaboration with the Naloxone Advisory Group,
formed in the pre-clinical stages (http://drugs.ie/features/
feature/naloxone_the_welsh_experience).
Our approach was informed by the experiential learn-
ing theory that allowed trainees to experience the
process of Naloxone administration. Similar experiential
curricula have improved addiction management skills
and knowledge in medical students and paediatric resi-
dents elsewhere [20, 21]. The aims of the educational
session, described in the current study, were to ensure
that GP trainees had the skills to manage an overdose,
i.e. initiating contact with emergency services, perform-
ing CPR, using INN and acquiring sufficient knowledge,
understanding and motivation to be willing to undertake
INN distribution and training. The key learning out-
comes of the educational session were to teach GPs how
to i) recognise opioid overdose, ii) assemble INN, and
iii) administer INN (Table 2). Specific teaching and dis-
semination strategies for those receiving naloxone kits
will depend on the recommendations of the current pilot
project about whom should receive these kits (e.g.
people who use drugs, family members, lay health/social
care workers). Teaching and dissemination strategies will
then be developed and included for recipient groups.
Table 2 Learning outcomes, delivery method/content and initial
evaluation of the session
Learning outcomes
• To recognise opioid overdose
• To assemble naloxone
• To administer INN
Delivery method
• Formal presentation
• Video demonstrations of how to i) recognise opioid overdose,
ii) assemble naloxone, and iii) administer INN
• Practical exercises on how to assemble and administer INN
• Q & A discussion
• Repeated measures assessment/feedback
Evaluation of education session
• Perceived changes in knowledge and attitudes
• Qualitative data on strengths/weaknesses
• Anonymous and confidential
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Data collection
A repeated-measures design using the validated Opioid
Overdose Knowledge (OOKS) and Attitudes (OOAS)
Scales examined changes immediately after the training
session [22]. The acceptability of and satisfaction with
this training were measured with a self-administered
questionnaire immediately after the session, which in-
cluded the acceptability of the session, learning needs
and suggested improvements.
OOKS has 45 items organised in four sub-scales (risks,
signs, actions and naloxone use, range 0–45). The
OOAS has 28 items grouped in three sub-scales (compe-
tence, concerns and readiness, range 28–140). Both scales
were developed and psychometrically evaluated with a
convenience sample of friends and family members of
heroin users and healthcare professionals in England. Both
OOKS and OOAS were shown to be internally reliable
(Cronbach’s alpha = 0.83 and 0.90, respectively). Retest
after 14 days also showed fair-to-excellent values (OOKS,
ICC = 0.90 and OOAS, ICC = 0.82). Professionals scored
significantly higher on both scales than family members
[22]. We changed two questions about “needles” and de-
leted two items about “injecting” naloxone in the attitudes
scale (new range 26–130). The original scales were for
injectable Naloxone; we used the intranasal formulation.
We acknowledge the potential threat to validity and reli-
ability, although the changes were minor.
The acceptability of the single session to trainees was
assessed with open-ended questions that asked them to
write what was good or bad about each of the five training
delivery methods, or teaching modalities. The trainees
rated each session based on its usefulness (5-point Likert
scales); the rating scales were taken from our previous
study [23].
Data analysis
We used the non-parametric Wilcoxon Paired Signed
Rank test for our analysis (IBM SPSS, version 20). We
report means and standard deviations. For the composite
usefulness score, all participants’ Likert scale scores were
added together, and the means and standard deviations
(SD) calculated. Answers to open-ended questions under-
went content analysis using the questions as the codes;
similar responses were grouped, groups were titled and
the number of responses counted. Using conventional
content analysis, coding groups (categories) were derived
directly from the text data [24].
Results
Pre-training and post-training knowledge
The educational session elicited significant changes in
three out of four knowledge categories (i.e., risks, actions
and use of naloxone, see Table 3). Furthermore, the
median composite knowledge score increased from 28
pre-training to 31 post-training (p < 0.001).
Skills
All participants were directly observed to have acquired
the skills needed to assemble and effectively deliver the
correct dose of naloxone in a safe manner. All delivered
INN following the procedures described by the CPG, rather
than simply spraying the dose into the nose.
Pre-training and post-training attitudes
There was a significant increase in all three categories
(competencies, concerns and readiness) of positive attitudes
towards overdose management (Table 3). The median
composite score for attitudes increased from 96 pre-
training to 108 post-training (p < 0.001).
Evaluation of the educational session
The group mean for the session usefulness score was 21.9
(out of 25); the most and the least useful delivery methods
were simulation and video respectively (see Table 4).
Most of the participants (74 %) felt their questions
were answered and saw a potential for the INN or over-
dose prevention in their training practice. The part of
the presentation that trainees liked the most was that it
“provided answers to the questions I had just asked”
(participant quote). It could have been “less rushed, more
interactive” (participant quote).
In the video, the trainees were able to “actually see the
device [Mucosal Atomiser Device]” (participant quote).
The video’s sound could be improved. During the
practical simulation it was “helpful to see how easy it
is [administration]” (participant quote); more time could
be spent on this. The trainees perceived the small Q & A
discussion as an “opportunity to ask questions” (participant
quote). One commented, “would be nice to discuss pros/
cons of lay people having naloxone and where GP would
avail of it”.
Finally, trainees were given an opportunity to com-
ment on their educational needs or provide suggestions
for improving the session (Table 4). Several wanted more
examples or real life situations to try, and two other
trainees wished for more time or booster sessions:
“very quick session so difficult to fully answer all Q’s
[questions], however, very useful and would definitely
allow us/help us to know what to do in OD setting”
(participant quote).
Discussion
This educational session, informed by a Clinical Practice
Guideline (CPG), has significantly improved knowledge
of and positive attitudes towards overdose management
among GP trainees. Based on the mean Likert-scales
scores, the most useful components of the training were
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simulation, presentation and Q & A discussion, with GP
trainees appreciating the opportunity to ask questions.
Our findings are consistent with the literature that
highlights the effectiveness of education in improving
knowledge of and attitudes towards overdose management
[25, 26]. Other studies successfully trained people who used
drugs [27], their families or friends [6], needle exchange
workers [28], police and fire-fighters [29]. The various
lengths and formats of training reported in this literature
suggest that less training may be needed than we thought
[30]; for instance, participants in a recent UK trial saved a
comparable number of people with naloxone regardless of





Mean diff (SD) Wilcoxon Z/P-value
Knowledge: 28/27.9 (4.5) 31/31.4 (1.5) 3.5 (4.5) −3.50, 0.000
Risks 8/7.5 (1.9) 9/8.7 (0.7) 1.17 (2.1) −2.69, 0.007
Signs 6/6.0 (1.8) 6/6.4 (0.7) 0.4 (1.9) −0.80, 0.422
Actions 6/5.5 (1.2) 6/6.4 (1.1) 1.0 (1.3) −3.04, 0.002
INN use 9/9.0 (1.2) 10/10.0 (0.7) 1.1 (1.3) −3.09, 0.002
Attitudes: 96/97.4 (7.2) 108/108.6 (8.1) 11.1 (6.4) −4.11, 0.000
Competencies 33/33.7 (4.7) 41/41.0 (3.9) 7.4 (5.0) −4.11, 0.000
Concerns 22/22.1 (2.6) 24/24.0 (2.9) 2.0 (2.2) −3.46, 0.001
Readiness 40/41.7 (3.3) 43/43.5 (3.9) 1.7 (2.8) −2.63, 0.008






Presentation 23 (100) 0 0 4.5 (0.5)
Video 19 (82.6) 3 (13.0) 1 (4.3) 4.2 (0.8)
Simulation 23 (100) 0 0 4.6 (0.5)
Q & A discussion 21 (91.3) 2 (8.7) 0 4.3 (0.6)
Guideline demonstration 20 (87) 3 (13.0) 0 4.4 (0.7)
Table 4 Acceptability of the educational session
How did you find each aspect of the session?
What was good about it? How can it be improved?
Presentation - Clear 4/15a
- Informative 7/15
- Concise 8/15
- Less rushed, more interactive 2/3
- Stimulating questions 1/3
Video - Visual 3/11
- Practical or demonstrative 5/11
- Clear 2/11
- Audio 6/7- More time 1/7
Simulation - Hands on experience of usage 13/18
- Informative 2/18
- Demonstrated ease of use, increased confidence 3/18




Q & A discussion - Opportunity to ask questions 4/6
- Collaborative 1/6
- Good/clear 2/6
- No major questions asked 2/5
- More time 1/5
- Naloxone for lay people and access for GPs 1/5
Would any other educational interventions/activities help trainees?
• Booster sessions 1/9
• More simulations/real life situations 3/9
• More samples, syringes, differences between IN and exact-dose-dispenser 4/9
Suggestions for improvement:
• Booster sessions 3/8
• More time 2/8
• Scenarios 1/8
• Very/good 2/8
aFractions indicate how many trainees reported about the particular item out of the total number of trainees who responded to the question
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whether they received the full training or information only
(five vs three controls), over a three months follow up [6].
Our training session produced slightly higher changes in
positive attitudes, and compared to the UK trial it was
linked with greater competence and confidence, though we
could not demonstrate impact on the provider behaviour in
an overdose situation. The changes in the attitudes towards
and willingness to intervene in an opioid overdose suggest
that our trainees would have used naloxone should they be
provided with a take-home dose.
The feasibility and acceptability of our session for GP
trainees were comparable with previous research in other
groups [29, 31–33]. In this study, some aspects of the edu-
cational session were more helpful than has been reported
in previous literature, i.e. hands-on experience with mate-
rials and GP access to INN kit [27].
The focus of the training session developed in this
pilot project was on intranasal naloxone and general
practice (GP). This hasn’t been done before. While the
target population of the training session was unusual,
the GP trainees clearly demonstrated improved skill,
knowledge and willingness to intervene in a possible opi-
oid overdose. Recognising this implication should shift
our thinking about the role of GPs in the management
and prevention of overdoses. In the literature, GPs tend
to be overlooked as a possible training or distribution
avenue. This route may be a unique component of a
national roll-out of the naloxone strategy [34], and, as
evident in our findings, one acceptable to doctors in
training. The decision to focus the educational session
on the GP trainees was influenced mainly by a recent
Scottish pre-implementation study [12], and the frequent
contact that GPs have with patients in methadone main-
tenance treatment in Ireland [35] or elsewhere [36]. The
Scottish pre-implementation study indicated that general
practice may be a viable route for distributing naloxone
in the community; while half of the GPs were unsure
about GP-based naloxone, the other half were willing to
provide this drug to family or buddies of opioid users.
Intranasal naloxone (INN) is a needleless, safe and
effective alternative to intramuscular formulations
[13, 14, 37–39]. Future studies should use INN for
training and distribution, especially because of its safety
for both bystanders (e.g. reduced fear of injury), and for
opioid users (e.g. less suspicion from police if naloxone is
found, although in the United States, it does not mean less
suspicion or problems with the police and people may fear
that possession of naloxone means that the person is using
drugs.). The legal situation in Ireland is currently under
governmental review and changes in the legal status of
Naloxone are expected to make it more broadly available
[40]. If the current prescription-only status is relaxed, GPs
may have greater clarity about their prescribing responsi-
bilities and more flexibility in their dissemination of these
kits. The challenge for future research and education is
also to incorporate INN training into medical education
and to engage other groups of service providers and
clients to use INN and to prevent overdoses.
The current study is limited in several ways. Our find-
ings are not generalizable to the larger population of
GPs involved in addiction treatment. The GP trainees
participated voluntarily, and were not obliged to take
part in the training or to apply their learning in practice.
Just because doctors can use naloxone does not imply
that they can or will train others in its use. It would be
useful to include qualitative questions about provider in-
tent to use their new knowledge. Our core focus on the
application of a validated Framework For Development
Of Complex Health Interventions by U.K. Medical Re-
search Council (MRC) [17], together with the repeated-
measures design, suggests the intervention’s potential,
and future research may determine whether it is general-
isable to other GPs inside or outside of Ireland. For ex-
ample, because providers in different locations were not
assessed, it would be worthwhile to pursue this in a future
study. The results from this study can be used to tailor the
training session for physicians and re-evaluate it. It would
be worthwhile to do longer-term follow up of this group
to see if they retained their knowledge or positive atti-
tudes, changed their practice, or both. Given the previous
trial among British families [6], a randomized evaluation
of the INN would be worthwhile.
Conclusion
General practice trainees can be trained to support
bystander response to overdose with intranasal naloxone.
Appropriate training is a key requirement for the distribu-
tion of naloxone through general practice. In future
studies, our educational session should be used to inform a
train-the-trainer model, whereby GPs and healthcare pro-
fessionals or other frontline service providers are trained to
train opioid users and their families in overdose prevention
and naloxone use. If feasible, such research can ex-
pand the role of general practice in the management
of opioid overdose and the distribution of naloxone to
opioid users, friends, families, frontline service providers
and other professions.
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